Natural CD4 CD25 FOXP3 regulatory T cells in graftversus-host disease - Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation - page 266

[146] Ratajczak P, Janin A, Peffault de Latour R, Leboeuf C, Desveaux A, Keyvanfar K, et al.
Th17/Treg ratio in human graft-versus-host disease. Blood 2010;116:1165-71.
[147] Brunstein CG, Miller JS, Cao Q, McKenna DH, Hippen KL, Curtsinger J, et al. Infusion
of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood:
safety profile and detection kinetics. Blood 2011;117:1061-70.
[148] Di Ianni M, Falzetti F, Carotti A, Terenzi A, Castellino F, Bonifacio E, et al. Tregs prevent
GVHD and promote immune reconstitution in HLA-haploidentical transplantation.
Blood 2011;117:3921-8.
[149] Di Ianni M, Del Papa B, Cecchini D, Bonifacio E, Moretti L, Zei T, et al. Immunomag-
netic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical
applications. Clin Exp Immunol 2009;156:246-53.
[150] Hoffmann P, Boeld TJ, Eder R, Albrecht J, Doser K, Piseshka B, et al. Isolation of
CD4+CD25+ regulatory T cells for clinical trials. Biol Blood Marrow Transplant
2006;12:267-74.
[151] Hoffmann P, Eder R, Kunz-Schughart LA, Andreesen R, Edinger M. Large-scale
in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood
2004;104:895-903.
[152] Godfrey WR, Ge YG, Spoden DJ, Levine BL, June CH, Blazar BR, et al. In vitro-expanded
human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic
cell-stimulated MLR cultures. Blood 2004;104:453-61.
[153] Valmori D, Merlo A, Souleimanian NE, Hesdorffer CS, Ayyoub M. A peripheral circulat-
ing compartment of natural naive CD4 Tregs. J Clin Invest 2005;115:1953-62.
[154] Seddiki N, Santner-Nanan B, Tangye SG, Alexander SI, Solomon M, Lee S, et al. Persis-
tence of naive CD45RA+ regulatory T cells in adult life. Blood 2006;107:2830-8.
[155] Hoffmann P, Boeld TJ, Eder R, Huehn J, Floess S, Wieczorek G, et al. Loss of FOXP3
expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro
stimulation. Eur J Immunol 2009;39:1088-97.
[156] Hansmann L, Schmidl C, Kett J, Steger L, Andreesen R, Hoffmann P, et al. Dominant
Th2 differentiation of human regulatory T cells upon loss of FOXP3 expression. J Im-
munol 2012;188:1275-82.
[157] Battaglia M, Stabilini A, Roncarolo MG. Rapamycin selectively expands
CD4+CD25+FoxP3+ regulatory T cells. Blood 2005;105:4743-8.
[158] Strauss L, Whiteside TL, Knights A, Bergmann C, Knuth A, Zippelius A. Selective survival
of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapa-
mycin. J Immunol 2007;178:320-9.
[159] Bensinger SJ, Walsh PT, Zhang J, Carroll M, Parsons R, Rathmell JC, et al. Distinct IL-2
receptor signaling pattern in CD4+CD25+ regulatory T cells. J Immunol 2004;172:
5287-96.
[160] Crellin NK, Garcia RV, Levings MK. Altered activation of AKT is required for the sup-
pressive function of human CD4+CD25+ T regulatory cells. Blood 2007;109:2014-22.
[161] Zeiser R, Leveson-Gower DB, Zambricki EA, Kambham N, Beilhack A, Loh J, et al. Dif-
ferential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+
regulatory T cells compared with conventional CD4+ T cells. Blood 2008;111:453-62.
[162] Valmori D, Tosello V, Souleimanian NE, Godefroy E, Scotto L, Wang Y, et al. Rapamycin-
mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell
cultures is not due to the selective expansion of naturally occurring regulatory T cells
but to the induction of regulatory functions in conventional CD4+ T cells. J Immunol
2006;177:944-9.
[163] Shin HJ, Baker J, Leveson-Gower DB, Smith AT, Sega EI, Negrin RS. Rapamycin and IL-2
reduce lethal acute graft-versus-host disease associated with increased expansion of
donor type CD4+CD25+Foxp3+ regulatory T cells. Blood 2011;118:2342-50.
[164] Coenen JJ, Koenen HJ, van Rijssen E, Kasran A, Boon L, Hilbrands LB, et al. Rapamy-
cin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+
CD25+ FoxP3+ T cells. Bone Marrow Transplant 2007;39:537-45.
[165] Hippen KL, Harker-Murray P, Porter SB, Merkel SC, Londer A, Taylor DK, et al. Umbili-
cal cord blood regulatory T-cell expansion and functional effects of tumor necrosis
factor receptor family members OX40 and 4-1BB expressed on artificial antigen-
presenting cells. Blood 2008;112:2847-57.
[166] Hippen KL, Merkel SC, Schirm DK, Sieben CM, Sumstad D, Kadidlo DM, et al. Massive
ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of
in vivo functional activity. Sci Transl Med 2011;3:83ra41.
[167] Veerapathran A, Pidala J, Beato F, Yu XZ, Anasetti C. Ex vivo expansion of human Tregs
specific for alloantigens presented directly or indirectly. Blood 2011;118:5671-80.
[168] Albert MH, Liu Y, Anasetti C, Yu XZ. Antigen-dependent suppression of alloresponses
by Foxp3-induced regulatory T cells in transplantation. Eur J Immunol 2005;35:2598-
607.

269